HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

propanoldiaminetetracetic acid

Also Known As:

PDTA

Networked: 16 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Polyamines: 3918
    - Diamines: 518
      - Ethylenediamines: 7
        Edetic Acid: 3051
        propanoldiaminetetracetic acid: 16
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - Edetic Acid: 3051
        propanoldiaminetetracetic acid: 16

Experts

1.	Chen, Xianjun: 2 articles (04/2022 - 01/2020)
2.	Gao, Feng: 2 articles (04/2022 - 01/2020)
3.	He, Muye: 2 articles (04/2022 - 01/2020)
4.	Hou, Xinyu: 2 articles (04/2022 - 01/2020)
5.	Lan, Minbo: 2 articles (04/2022 - 01/2020)
6.	Xu, Jiajun: 2 articles (04/2022 - 01/2020)
7.	Yang, Yi: 2 articles (04/2022 - 01/2020)
8.	Zhao, Yuzheng: 2 articles (04/2022 - 01/2020)
9.	Brunetti, Natale Daniele: 1 article (05/2022)
10.	Caldarola, Pasquale: 1 article (05/2022)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 12/01/2021 - "[Target therapy and governance: the breast cancer PDTA of the Venetian Oncology Network.]" 11/22/2023 - "In vitro investigations have indicated that pDTA-Tig@CML, with its ability to sequentially release Tig and pDTA, effectively suppresses platelet activity, resulting in improved therapeutic outcomes and the mitigation of platelet driven metastasis in breast cancer. " 11/22/2023 - "Consequently, pDTA-Tig@CML emerges as a promising light-switchable DTA transgene system, offering a novel bioactivating prodrug platform for breast cancer treatment."
2.	Neoplasm Metastasis (Metastasis) 11/22/2023 - "In vitro investigations have indicated that pDTA-Tig@CML, with its ability to sequentially release Tig and pDTA, effectively suppresses platelet activity, resulting in improved therapeutic outcomes and the mitigation of platelet driven metastasis in breast cancer. " 11/22/2023 - "Furthermore, pDTA-Tig@CML exhibits enhanced tumor aggregation and successfully restrains tumor growth and metastasis. "
3.	Neoplasms (Cancer) 01/01/2020 - "In vitro studies suggested that pG&pDTA@cRGD-CL exerted arrest of the S phase in B16F10 cells upon blue light irradiation and, ultimately, induced the apoptosis and necrosis of tumor cells. " 11/22/2023 - "Furthermore, pDTA-Tig@CML exhibits enhanced tumor aggregation and successfully restrains tumor growth and metastasis. " 04/25/2022 - "We developed a nanoparticle drug delivery system to achieve tumor microenvironment-responsive and targeted delivery of DTA-encoded plasmids (pDTA) to tumor sites via dual targeting to cluster of differentiation-44 and αvβ3 receptors. " 04/25/2022 - "In vivo studies indicated that the combination of pDTA and losartan reduce the concentration of collagen type I from 5.9 to 1.9 µg/g and decreased the level of active transforming growth factor-β by 75.0% in tumor tissues. "
4.	Necrosis 01/01/2020 - "In vitro studies suggested that pG&pDTA@cRGD-CL exerted arrest of the S phase in B16F10 cells upon blue light irradiation and, ultimately, induced the apoptosis and necrosis of tumor cells. "
5.	Chronic Obstructive Pulmonary Disease (COPD) 01/01/2022 - "The active COPD PDTA in ASL Roma 2 seems to hit the target of taking care of the patient in the early stages of the disease. " 01/01/2022 - "In the Lazio Region, the Clinical Pathway (PDTA) for COPD was codified in 2016. " 09/01/2015 - "The diagnostic and therapeutic pathways activated (PDTA), involved four chronic conditions, selected according to the prevalence and incidence, in Tuscany Region: Diabetes Mellitus (DM), Heart Failure (SC), Chronic Obstructive Pulmonary Disease (COPD) and stroke. "

Related Drugs and Biologics

1.	Collagen Type I (Type I Collagen)
2.	Losartan (Cozaar)
3.	Transforming Growth Factors (Transforming Growth Factor)
4.	Ruthenium
5.	Prodrugs
6.	DNA (Deoxyribonucleic Acid)
7.	Methanol (Carbinol)
8.	Nanoparticle Drug Delivery System

Related Therapies and Procedures

1.	Therapeutics